Literature DB >> 27446410

Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up.

Markku H Vaarala1, Aare Mehik1, Pasi Ohtonen1, Pekka A Hellström1.   

Abstract

Controversy exists regarding a possible association between prostatitis and prostate cancer. To further evaluate the incidence of prostate cancer following prostatitis, a study of prostate cancer incidence in a cohort of Finnish men was performed. The original survey evaluating self-reported prostatitis was conducted in 1996-1997. A database review was conducted focusing on prostate cancer diagnoses in the cohort. In 2012, there were 13 (5.2%) and 27 (1.8%) prostate cancer cases among men with (n=251) and without (n=1,521) prostatitis symptoms, respectively. There were no significant differences in age, primary therapy distribution, prostate-specific antigen levels, Gleason score, clinical T-class at the time of prostate cancer diagnosis, or time lag between the original survey and prostate cancer diagnosis. The standardized incidence ratio (SIR) of prostate cancer was 1.16 [95% confidence interval (CI), 0.62-1.99] and 0.44 (95% CI, 0.29-0.64) among men with and without prostatitis symptoms, respectively. After 15 years of follow-up subsequent to self-reported prostatitis, no evident increase in incidence of prostate cancer was detected among Finnish men with prostatitis symptoms. The higher percentage of prostate cancer among men with prostatitis symptoms appears to be due to coincidentally low SIR of prostate cancer among men without prostatitis symptoms, and may additionally be due to increased diagnostic examinations. Further research is required to confirm this speculation.

Entities:  

Keywords:  epidemiology; inflammation; prostate cancer; prostatitis

Year:  2016        PMID: 27446410      PMCID: PMC4950901          DOI: 10.3892/ol.2016.4702

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  Correlates and prevalence of prostatitis in a large community-based cohort of older men.

Authors:  Nicholas A Daniels; Susan K Ewing; Joseph M Zmuda; Timothy J Wilt; Douglas C Bauer
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

2.  Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study.

Authors:  A Mehik; P Hellström; O Lukkarinen; A Sarpola; M Järvelin
Journal:  BJU Int       Date:  2000-09       Impact factor: 5.588

3.  High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group.

Authors:  J Irani; J M Goujon; E Ragni; L Peyrat; J Hubert; F Saint; N Mottet
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

Review 4.  Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis".

Authors:  J N Krieger; K J Egan; S O Ross; R Jacobs; R E Berger
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

5.  Prevalence and correlates of prostatitis in the health professionals follow-up study cohort.

Authors:  Mary McNaughton Collins; James B Meigs; Michael J Barry; Elizabeth Walker Corkery; Edward Giovannucci; Ichiro Kawachi
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

6.  Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.

Authors:  Rachel S Edlin; Chris F Heyns; Stephan P J Van Vuuren; Amir D Zarrabi
Journal:  S Afr J Surg       Date:  2012-11-12       Impact factor: 0.375

7.  Prostatitis as a risk factor for prostate cancer.

Authors:  Rosebud O Roberts; Erik J Bergstralh; Sarah E Bass; Michael M Lieber; Steven J Jacobsen
Journal:  Epidemiology       Date:  2004-01       Impact factor: 4.822

8.  Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.

Authors:  J Curtis Nickel; Claus G Roehrborn; Michael P O'leary; David G Bostwick; Matthew C Somerville; Roger S Rittmaster
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

9.  Chronic inflammation of the prostate type IV with respect to risk of prostate cancer.

Authors:  Antonio B Porcaro; Emanuele Rubilotta; Aldo Petrozziello; Claudio Ghimenton; Filippo Migliorini; Stefano Zecchini Antoniolli; Vincenzo Lacola; Carmelo Monaco; Pierpaolo Curti; Stefano Cavalleri; Romeo Pianon; Walter Artibani
Journal:  Arch Ital Urol Androl       Date:  2014-09-30

10.  Chronic asymptomatic inflammation of the prostate type IV and carcinoma of the prostate: is there a correlation?

Authors:  P F Engelhardt; H Brustmann; S Seklehner; C R Riedl
Journal:  Scand J Urol       Date:  2012-10-22       Impact factor: 1.612

View more
  3 in total

1.  Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.

Authors:  Cheng-Fan Lee; Andrew Dang; Elizabeth Hernandez; Rey-Chen Pong; Benjamin Chen; Rajni Sonavane; Ganesh Raj; Payal Kapur; Hsin-Ying Lin; Shang-Ru Wu; Chun-Jung Ko; U-Ging Lo; Hsin-Yu Lee; Jer-Tsong Hsieh; Ming-Shyue Lee
Journal:  Oncogene       Date:  2019-05-31       Impact factor: 9.867

2.  Genetic and Environmental Influences on Urinary Conditions in Men: A Classical Twin Study.

Authors:  Marianna Gasperi; John N Krieger; Matthew S Panizzon; Jack Goldberg; Dedra Buchwald; Niloofar Afari
Journal:  Urology       Date:  2019-04-13       Impact factor: 2.649

3.  Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis.

Authors:  Lei Zhang; Yi Wang; Zhiqiang Qin; Xian Gao; Qianwei Xing; Ran Li; Wei Wang; Ninghong Song; Wei Zhang
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.